Cargando…

Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches

Systemic sclerosis (SSc) is a systemic, immune-mediated chronic disorder characterized by small vessel alterations and progressive fibrosis of the skin and internal organs. The combination of a predisposing genetic background and triggering factors that causes a persistent activation of immune syste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Benfaremo, Devis, Svegliati, Silvia, Paolini, Chiara, Agarbati, Silvia, Moroncini, Gianluca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773282/ https://www.ncbi.nlm.nih.gov/pubmed/35052842 http://dx.doi.org/10.3390/biomedicines10010163

Ejemplares similares

Skin Gene Expression Profiles in Systemic Sclerosis: From Clinical Stratification to Precision Medicine
por: Benfaremo, Devis, et al.
Publicado: (2023)

PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis
por: Paolini, Chiara, et al.
Publicado: (2022)

Screening and Analysis of Possible Drugs Binding to PDGFRα: A Molecular Modeling Study
por: Mozzicafreddo, Matteo, et al.
Publicado: (2023)

Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis
por: Agarbati, S., et al.
Publicado: (2022)

Agonistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cells Function In Vitro
por: Svegliati, Silvia, et al.
Publicado: (2017)

Corrigendum: Agonistic Anti-PDGF Receptor Autoantibodies from Patients with Systemic Sclerosis Impact Human Pulmonary Artery Smooth Muscle Cells Function In Vitro
por: Svegliati, Silvia, et al.
Publicado: (2017)

Mesenchymal stromal cells from human umbilical cord prevent the development of lung fibrosis in immunocompetent mice
por: Moroncini, Gianluca, et al.
Publicado: (2018)

Current Take on Systemic Sclerosis Patients’ Vaccination Recommendations
por: Murdaca, Giuseppe, et al.
Publicado: (2021)

Discharge from the emergency department and early hospital revaluation in patients with COVID-19 pneumonia: a prospective study
por: Mattioli, Massimo, et al.
Publicado: (2022)

New Insights into the Role of Oxidative Stress in Scleroderma Fibrosis
por: Gabrielli, Armando, et al.
Publicado: (2012)

6 and 12 month outcomes in patients following COVID-19-related hospitalization: a prospective monocentric study
por: Martino, Giuseppe Pio, et al.
Publicado: (2022)

The Microbiome in Systemic Sclerosis: Pathophysiology and Therapeutic Potential
por: Kim, Suhee, et al.
Publicado: (2022)

Is There a Future for Anti-CD38 Antibody Therapy in Systemic Autoimmune Diseases?
por: Benfaremo, Devis, et al.
Publicado: (2019)

Real-life efficacy and safety of nintedanib in systemic sclerosis-interstitial lung disease: data from an Italian multicentre study
por: Campochiaro, Corrado, et al.
Publicado: (2023)

Diagnosis and management of leukocytoclastic vasculitis
por: Fraticelli, Paolo, et al.
Publicado: (2021)

New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review
por: Perrotta, Fabio Massimo, et al.
Publicado: (2021)

Biomarkers in Inflammatory Bowel Disease-Associated Spondyloarthritis: State of the Art and Unmet Needs
por: Benfaremo, Devis, et al.
Publicado: (2019)

Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches
por: Campanati, Anna, et al.
Publicado: (2021)

Basal Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches
por: Fania, Luca, et al.
Publicado: (2020)

Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients
por: Danieli, Maria Giovanna, et al.
Publicado: (2022)

Cutaneous Squamous Cell Carcinoma: From Pathophysiology to Novel Therapeutic Approaches
por: Fania, Luca, et al.
Publicado: (2021)

SARS-COV-2 Infection, Vaccination, and Immune-Mediated Diseases: Results of a Single-Center Retrospective Study
por: Luchetti Gentiloni, Michele Maria, et al.
Publicado: (2022)

Pathophysiology of Non Alcoholic Fatty Liver Disease
por: Petta, Salvatore, et al.
Publicado: (2016)

Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis
por: Rosa, Irene, et al.
Publicado: (2021)

Neurodevelopmental Disorders: From Pathophysiology to Novel Therapeutic Approaches
por: Kosel, Markus, et al.
Publicado: (2022)

Endothelial Dysfunction: From Pathophysiology to Novel Therapeutic Approaches
por: Jeon, Byeong Hwa
Publicado: (2021)

Colorectal Cancer: From Pathophysiology to Novel Therapeutic Approaches
por: Barresi, Valeria
Publicado: (2021)

Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis
por: Li, Wenxue, et al.
Publicado: (2022)

Emerging Role of Extracellular Vesicles in the Pathophysiology of Multiple Sclerosis
por: Dolcetti, Ettore, et al.
Publicado: (2020)

Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases
por: Bellan, Mattia, et al.
Publicado: (2020)

Advancing the understanding of allergic contact dermatitis: from pathophysiology to novel therapeutic approaches
por: Tramontana, Marta, et al.
Publicado: (2023)

Metabolomic profile of systemic sclerosis patients
por: Murgia, Federica, et al.
Publicado: (2018)

Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy
por: Benfaremo, Devis, et al.
Publicado: (2021)

Cirrhotic portal hypertension: From pathophysiology to novel therapeutics
por: Gunarathne, Lakmie S, et al.
Publicado: (2020)

Vascular pathologies in chronic kidney disease: pathophysiological mechanisms and novel therapeutic approaches
por: Düsing, Philip, et al.
Publicado: (2021)

Pathophysiology and Therapeutic Approaches for Spinal Cord Injury
por: Lima, Rui, et al.
Publicado: (2022)

The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology
por: Buscarinu, Maria Chiara, et al.
Publicado: (2019)

Novel Therapeutic Strategies in the Treatment of Systemic Sclerosis
por: Gumkowska-Sroka, Olga, et al.
Publicado: (2023)

Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature
por: Benfaremo, Devis, et al.
Publicado: (2018)

Breast Cancer: From Pathophysiology to Novel Therapeutic Approaches 2.0
por: Zannetti, Antonella
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h2tl9d5sno27ua7ol2i26rd201